Search
Search Results
##search.searchResults.foundPlural##
-
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1782PDF: 1090HTML: 236 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1470PDF: 736HTML: 821jdoe, table 2 infections CML .doc: 156jdoe, table 1 infections CML .doc: 147 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
1862PDF: 1744HTML: 317 -
Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome
3313PDF: 920HTML: 382Table 1.: 198 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3849PDF: 1236HTML: 2232 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2837PDF: 919HTML: 2038Cover letter: 154 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3089PDF: 1463HTML: 382 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1152PDF: 879HTML: 74 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2057PDF: 894HTML: 4984Cover Letter: 140Figure 2: 127Figure 1: 140Figure 3: 150Figure 4: 133Figure Legend: 151Table 1: 154Table 2: 145Table 3: 148 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
2968PDF: 943HTML: 398 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
2903PDF: 1499HTML: 244 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1189PDF: 725HTML: 425 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3414PDF: 1224HTML: 650Figure 2: 407Figure 1: 3073 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3224PDF: 551HTML: 608 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1644PDF: 482HTML: 16949Figure 4: 136Figure 3: 116Figure 2: 115Figure 1: 145 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2425PDF: 862HTML: 15056 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2440PDF: 879HTML: 3550 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1179PDF: 959HTML: 100 -
High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding
2014PDF: 770HTML: 925Untitled: 236 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
1787PDF: 789HTML: 269 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1129PDF: 809HTML: 1081Coverletter: 161 -
-
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1012PDF: 851HTML: 276 -
Postpandemic influenza A/H1N1pdm09 is still causing severe perinatal complications
1268PDF: 938HTML: 1989Cover letter: 161 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2301HTML: 9363DOCX: 941Tables Dengue: 183 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3023PDF: 1341HTML: 5824Fig1-Ag-Pil: 173Ag-Pil Fig.2: 168 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2163PDF: 846HTML: 435 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1087PDF: 672HTML: 271 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
1575HTML: 478PDF: 1016







